US$ 27.03
retatrutide triple agonist glp-1 gip glucagon ly3437943 Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor
Description
Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)

Allulose, a rare sugar, has been shown to stimulate GLP-1, reduce blood sugar spikes, and help control appetite without the side effects of medications

This breakthrough formula fires up GLP-1 production to fend off cravings, especially those carb-loaded temptations

Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.
